Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | CPT2 | P23786 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | PAM | P19021 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28096696 | 0.85 | DGKA (0.50) | DGKALMNAFFAR1TDP1TSHR | |
| SCHEMBL5603689 | 0.85 | DGKA (0.37) | DGKAEPHX2LMNAFFAR1CPT2 | |
| SCHEMBL24813044 | 0.84 | PAOX (0.44) | DGKAEPHX2LMNATSHRALDH1A1 | |
| SCHEMBL28650658 | 0.84 | DGKA (0.40) | DGKALMNATSHRPAMALDH1A1 | |
| Water SCHEMBL28184192 | 0.84 | DGKA (0.36) | DGKAEPHX2LMNAFFAR1CPT2 | |
| SCHEMBL27473319 | 0.83 | DGKA (0.47) | DGKALMNATSHRPAMALDH1A1 | |
| SCHEMBL3689198 | 0.82 | EPHX2 (0.43) | DGKAEPHX2LMNAFFAR1CPT2 | |
| SCHEMBL1880277 | 0.82 | EPHX2 (0.43) | DGKAEPHX2LMNAFFAR1CPT2 | |
| SCHEMBL16863814 | 0.82 | EPHX2 (0.43) | DGKAEPHX2LMNAFFAR1CPT2 | |
| SCHEMBL10250201 | 0.82 | EPHX2 (0.43) | DGKAEPHX2LMNAFFAR1CPT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 205 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170102347-A1 | BIOCHEMICAL TEST CHIP | APEX BIOTECHNOLOGY CORP. (TW) | 2017-04-13 | — | — | US | claimed |
| EP-3153857-A1 | BIOCHEMICAL TEST CHIP | Apex Biotechnology Corporation (TW) | 2017-04-12 | — | — | EP | claimed |
| CN-102993346-B | Vinyl chloride resin paste composition and method for preparing vinyl chloride resin paste with excellent polymerization heat control performance using the same | LG CHEM, LTD. (KR) | 2016-01-13 | — | — | CN | claimed |
| CN-102993346-A | Vinyl chloride resin paste composition and method for preparing vinyl chloride resin paste with excellent polymerization heat control performance using the same | LG CHEMICAL LTD | 2013-03-27 | — | — | CN | claimed |
| CN-102952225-A | Suspension polymerization method for reducing polyvinyl chloride resin fisheyes | CHINA PETROLEUM & CHEMICAL | 2013-03-06 | — | — | CN | claimed |
| CN-1618866-A | Preparation method of polyvinyl chloride/inorganic rigid particle composite resin | UNIV HUADONG TECHNOLOGY (CN) | 2005-05-25 | — | — | CN | claimed |
| US-12359045-B2 | Oxazoline-modified polypropylene | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-07-15 | — | — | US | disclosed |
| WO-2024162063-A1 | AQUEOUS DISPERSION AND RESIN FILM FORMED FROM SAID AQUEOUS DISPERSION | 住友化学株式会社 | 2024-08-08 | — | — | WO | disclosed |
| EP-4389792-A1 | RESIN, METHOD FOR PRODUCING RESIN, CURABLE RESIN COMPOSITION, AND CURED OBJECT | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-06-26 | — | — | EP | disclosed |
| US-11781001-B2 | Propylene polymer composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-10-10 | — | — | US | disclosed |
| WO-2023021813-A1 | RESIN, METHOD FOR PRODUCING RESIN, CURABLE RESIN COMPOSITION, AND CURED OBJECT | 三菱瓦斯化学株式会社 | 2023-02-23 | — | — | WO | disclosed |
| WO-2022210053-A1 | MODIFIED POLYOLEFIN RESIN | 住友化学株式会社 | 2022-10-06 | — | — | WO | disclosed |
| WO-2022210054-A1 | AQUEOUS DISPERSION | 住友化学株式会社 | 2022-10-06 | — | — | WO | disclosed |
| US-20040132620-A1 | Melt knead graft polymerization with polar functionalized monomer; high level of incorporation | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-07-08 | — | — | US | disclosed |
| US-20040002569-A1 | Composite material of polyolefin resin and filler and molded article made from the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-01-01 | — | — | US | disclosed |
| CN-1434844-A | Acrylic polymer composition, acrylic pressure-sensitive adhesive tape, and method for producing same | SOKEN KAGAKU KK (JP) | 2003-08-06 | — | — | CN | disclosed |
| US-20030119996-A1 | Process for producing modified polypropylene resin | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-06-26 | — | — | US | disclosed |
| US-6569950-B2 | Peroxy curing agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-05-27 | — | — | US | disclosed |
| US-20020161131-A1 | Process for producing acid modified polypropylene resin | SUMITOMO CHEMICAL COMPANY, LIMITED | 2002-10-31 | — | — | US | disclosed |
| CN-1373145-A | Method for preparing acid-modified polypropylene resin | SUMITOMO CHEMICAL CO (JP) | 2002-10-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040132620-A1 | Melt knead graft polymerization with polar functionalized monomer; high level of incorporation | PPID, GRIN2D, KLHDC2 | DGKA 2656/4885EPHX2 759/4885LMNA 4424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.